Back to search
FDAFDA · Food and drugs·Recall number D-1342-2019

Zileuton Extended-Release Tablets, 600 mg, 120-count bottles, Rx only, Distributed by: Prasco Laboratories, Mason, OH 45040 USA; NDC 66993-485-32.

Published June 19, 2019 · Recall initiated: May 31, 2019

Summary

FDA records drug Class II recall D-1342-2019, published June 19, 2019 and initiated May 31, 2019. Recalling firm: Chiesi USA, Inc.; Status: Terminated; Reported quantity: 2598 bottles; Lot: Lots: 3171856, Exp. 12/19. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.

Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.

What's the hazard

Failed Dissolution Specifications: Out of specification result for dissolution.

What to do

Voluntary: Firm initiated · Letter

Get an email when a new FDA recall like this is published

Free. We only write when there's a new recall that matches. Unsubscribe in one click.

Recall details

Manufacturer
Chiesi USA, Inc.
Distributor
Nationwide in the USA.
Lot
Lots: 3171856, Exp. 12/19
Risk classification
Class II
Area (FDA)
drug
Country
United States

Related recalls

Questions about this recall

Was Zileuton Extended-Release Tablets, 600 mg, 120-count bottles, Rx only, Distributed by: Prasco Laboratories, Mason, OH 45040 USA; NDC 66993-485-32. recalled?

Yes. FDA published recall D-1342-2019 on June 19, 2019. Reported hazard: Failed Dissolution Specifications: Out of specification result for dissolution.

What should I do if I have this product?

Voluntary: Firm initiated · Letter